FINWIRES · TerminalLIVE
FINWIRES

$KMTS

6 stories mentioning KMTSUpdated just now

Every FINWIRES story that references KMTS, newest first.

Insider Trading

Kestra Medical Technologies Insider Sold Shares Worth $1,272,588, According to a Recent SEC Filing

Brian Daniel Webster, Director, President and Chief Executive Officer, on August 04, 2026, sold 51,900 shares in Kestra Medical Technologies (KMTS) for $1,272,588. Following the Form 4 filing with the SEC, Webster has control over a total of 475,215 common shares of the company, with 475,215 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1877184/000119312526338657/xslF345X05/ownership.xml

$KMTS
Wire

Kestra Medical's Bullish Fundamentals Driven by Large Total Addressable Market, Sustained Share Gains, Oppenheimer Says

Kestra Medical Technologies' (KMTS) bullish fundamentals are driven by a large total addressable market in the US, sustained share gains, and technology enhancements, Oppenheimer said in a Tuesday research note.The brokerage said it is seeking a better risk-reward entry point as share gains look priced into the stock, and true clinical differentiation of wearable cardiac defibrillators is difficult due to a lack of head-to-head trials.Analysts noted that their constructive view arises from the potential for the company's Assure wearable cardiac defibrillator to become a theranostics platform with multiple revenue drivers over time.The brokerage said it initiated coverage of the stock with a perform rating.Price: $23.00, Change: $-0.24, Percent Change: -1.03%

$KMTS
Research

Oppenheimer Initiates Kestra Medical at Market Perform

Kestra Medical (KMTS) has an average rating of buy and mean price target of $30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$KMTS
Insider Trading

Kestra Medical Technologies Insider Sold Shares Worth $336,609, According to a Recent SEC Filing

Brian Daniel Webster, Director, President, and Chief Executive Officer, on July 15, 2026, sold 15,000 shares in Kestra Medical Technologies (KMTS) for $336,609. Following the Form 4 filing with the SEC, Webster has control over a total of 556,937 common shares of the company, with 556,937 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1877184/000119312526308041/xslF345X05/ownership.xml

$KMTS
Insider Trading

Kestra Medical Technologies Insider Sold Shares Worth $312,143, According to a Recent SEC Filing

Brian Daniel Webster, Director, President and CEO, on June 15, 2026, sold 15,000 shares in Kestra Medical Technologies (KMTS) for $312,143. Following the Form 4 filing with the SEC, Webster has control over a total of 395,467 common shares of the company, with 395,467 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1877184/000119312526274257/xslF345X05/ownership.xml

$KMTS
Insider Trading

Kestra Medical Technologies Insider Sold Shares Worth $300,671, According to a Recent SEC Filing

Brian Daniel Webster, Director, President and Chief Executive Officer, on April 15, 2026, sold 15,000 shares in Kestra Medical Technologies (KMTS) for $300,671. Following the Form 4 filing with the SEC, Webster has control over a total of 349,786 common shares of the company, with 349,786 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1877184/000119312526159276/xslF345X05/ownership.xml

$KMTS

Track with the FINWIRES app suite

FolioX
FolioX
Track KMTS in your portfolio
WheelAI
WheelAI
Analyze KMTS options with the wheel strategy
StockInsider
StockInsider
See market sentiment on KMTS